“Pharmacoeconomic Comparison of Ziprasidone With Other Atypical Oral Antipsychotic Agents in Schizophrenia”. Farmeconomia. Health economics and therapeutic pathways 12, no. 1 (November 21, 2011): 29–40. Accessed October 29, 2025. https://journals.seedstm.com/index.php/FE/article/view/96.